RecruitingPhase 2NCT04535271

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

Studying Leiomyosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sarcoma Oncology Research Center, LLC
Principal Investigator
Sant P Chawla, MD
Sarcoma Oncology Research Center, LLC
Intervention
Trabectedin(drug)
Enrollment
80 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04535271 on ClinicalTrials.gov

Other trials for Leiomyosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Leiomyosarcoma →

← Back to all trials